Tsumura & Co.

Tokyo Stock Exchange 4540.T

Tsumura & Co. EBT Margin for the year ending March 31, 2024: 15.74%

Tsumura & Co. EBT Margin is 15.74% for the year ending March 31, 2024, a -4.27% change year over year. EBT Ratio (Earnings Before Tax Ratio) is the fraction of earnings before taxes to total revenue, indicating the company's profitability before the impact of tax expenses.

Tsumura & Co. EBT Margin for the year ending March 31, 2023 was 16.44%, a -16.71% change year over year.
Tsumura & Co. EBT Margin for the year ending March 31, 2022 was 19.73%, a 26.25% change year over year.
Tsumura & Co. EBT Margin for the year ending March 31, 2021 was 15.63%, a 0.21% change year over year.
Tsumura & Co. EBT Margin for the year ending March 31, 2020 was 15.60%, a -5.22% change year over year.

Key data

Date	EBT Margin	Net Income Margin	EBITDA Margin	EBIT Margin

Tokyo Stock Exchange: 4540.T

Tsumura & Co.

CEO	Mr. Terukazu Kato
IPO Date	Jan. 1, 2001
Location	Japan
Headquarters	2-17-11, Akasaka
Employees	4,138
Sector	Health Care
Industries Pharmaceuticals

Description

Tsumura & Co. engages in the manufacture and sale of pharmaceutical products worldwide. The company offers Kampo extract intermediates and granular Kampo formulations. It is involved in the procurement, selection and processing, and storage of raw material crude drugs and crude drug pieces for decoction; manufacture of Kampo powdered extracts and traditional Chinese medicines; and sale of pharmaceuticals and food products. The company was founded in 1893 and is headquartered in Tokyo, Japan.

Key trends

Past 5 years